Answers are grounded in this paper and cite their sources.
TGF-β is a multifunctional cytokine that plays a key role in embryogenesis and adult tissue homoeostasis.TGF-β is secreted by a myriad of cell types triggering a varied array of cellular functions including apoptosis, proliferation, migration, endothelial and mesenchymal transition, and extracellular matrix production.Downstream TGFβ responses can also be modulated by other signalling pathways (i.e.PI3K, ERK, WNT, etc.) resulting in a complex web of TGF-β pathway activation or repression depending on the nature of the signal and cellular context.Apart from TGF-β mediated cellautonomous effects TGF-β can further play an important function in regulating tumour microenvironments effecting the interaction between stromal fibroblasts and tumour cells.Due to the central role of TGF-β in cellular processes it is therefore unsurprising that loss of TGF-β pathway integrity is frequently observed in a variety of human diseases, including cancer.However, the TGF-β pathway plays a complex dual role in cancer.In normal epithelial cells and premalignant cells TGF-β acts a potent tumor suppressor eliciting a cytostatic response inhibiting tumor progression.Supporting this notion, inactivating mutations in members of the TGF-β pathway have been observed in a variety of cancers including pancreatic, colorectal, and head and neck cancer.In contrast, during tumor progression the TGF-β antiproliferative func-tion is lost, and in certain advanced cancers TGF-β becomes an oncogenic factor inducing cellular proliferation, invasion, angiogenesis, and immune suppression.As a consequence, the TGFβ pathway is currently considered a therapeutic target in advanced cancers and several anti-TGF-β agents in clinical trials have shown promising results [1,2].However, due to the complex dichotomous role of TGF-β in oncogenesis a detailed understanding of TGF-β biology is required in order to design successful therapeutic strategies to identify patient populations that will benefit most from these compounds.The last few years have begun to peel away the many facets of the TGF-β pathway including regulation of TGF-β kinetics by ubiquitination.This review specifically focuses on the role of ubiquitination in the regulation of TGF-β pathway components highlighting the ubiquitin regulating enzymes, which may potentially be targeted in human disease.
No takes yet. Share an insight, caveat, or question.
Pieter J.A. Eichhorn (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: